BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37516854)

  • 1. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
    Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
    World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X; Long Z; Cai H; Yu S; Wu J
    Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
    [No Abstract]   [Full Text] [Related]  

  • 3. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
    Liu M; Zhang X; Cai J; Li Y; Luo Q; Wu H; Yang Z; Wang L; Chen D
    Oncol Rep; 2018 Sep; 40(3):1251-1260. PubMed ID: 29956813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells.
    Yuan P; Zhou Y; Wang R; Chen S; Wang Q; Xu Z; Liu Y; Yang H
    Biomed Res Int; 2020; 2020():8450606. PubMed ID: 32219144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
    Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
    Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP.
    Shang R; Chen J; Gao Y; Chen J; Han G
    Dis Markers; 2023; 2023():5899662. PubMed ID: 36644609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 11. RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway.
    Zhou F; Wang L; Jin K; Wu Y
    Bioengineered; 2021 Dec; 12(1):5859-5869. PubMed ID: 34477047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABHD6 suppresses colorectal cancer progression via AKT signaling pathway.
    Xiong X; Yang C; Jin Y; Zhang R; Wang S; Gan L; Hou S; Bao Y; Zeng Z; Ye Y; Gao Z
    Mol Carcinog; 2024 Apr; 63(4):647-662. PubMed ID: 38197491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer.
    Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
    Int J Biochem Cell Biol; 2022 Feb; 143():106140. PubMed ID: 34954155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
    Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
    Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmocollin 3 has a tumor suppressive activity through inhibition of AKT pathway in colorectal cancer.
    Cui T; Yang L; Ma Y; Petersen I; Chen Y
    Exp Cell Res; 2019 May; 378(2):124-130. PubMed ID: 30857973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
    Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
    Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-methoxytryptophan induced apoptosis and PI3K/Akt/FoxO3a phosphorylation in colorectal cancer.
    Zhao TL; Qi Y; Wang YF; Wang Y; Liang H; Pu YB
    World J Gastroenterol; 2023 Dec; 29(47):6148-6160. PubMed ID: 38186686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
    Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis in vitro and in vivo.
    Huang H; Park S; Zhang H; Park S; Kwon W; Kim E; Zhang X; Jang S; Yoon D; Choi SK; Yi JK; Kim SH; Dong Z; Lee MH; Ryoo Z; Kim MO
    J Exp Clin Cancer Res; 2021 Mar; 40(1):114. PubMed ID: 33785035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.